Based on 1 analysts giving stock ratings to Creative Medical Technology Holdings Inc in the past month.
In the current month, CELZ has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CELZ average Analyst price target in the last month is 20.000.
Based on analysts' estimates, CELZ EPS is projected to reach -0.240 in FY2026Q4, following reported EPS of -0.401 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.40, while Creative Medical Technology Holdings IncCELZ's earnings per share (EPS) for the previous quarter was USD -0.41. EPS for the next quarter is expected at USD -0.24.